Boussard & Gavaudan Investment Management LLP bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 4,293 shares of the technology company's stock, valued at approximately $908,000.
Other large investors also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of Veeva Systems by 1.5% in the third quarter. State Street Corp now owns 3,293,141 shares of the technology company's stock worth $691,132,000 after purchasing an additional 47,872 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Veeva Systems by 17.5% in the 4th quarter. JPMorgan Chase & Co. now owns 3,005,633 shares of the technology company's stock worth $631,935,000 after acquiring an additional 447,041 shares during the last quarter. FMR LLC raised its holdings in shares of Veeva Systems by 25.7% during the 3rd quarter. FMR LLC now owns 2,981,244 shares of the technology company's stock worth $625,674,000 after acquiring an additional 610,021 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Veeva Systems by 36.0% during the 4th quarter. Principal Financial Group Inc. now owns 2,964,025 shares of the technology company's stock valued at $623,186,000 after acquiring an additional 784,741 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Veeva Systems by 5.7% in the third quarter. Geode Capital Management LLC now owns 2,765,236 shares of the technology company's stock valued at $579,630,000 after purchasing an additional 149,807 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Stock Down 2.1 %
NYSE:VEEV traded down $4.81 during mid-day trading on Tuesday, reaching $226.82. The company's stock had a trading volume of 922,105 shares, compared to its average volume of 1,157,160. Veeva Systems Inc. has a 1 year low of $170.25 and a 1 year high of $258.93. The stock has a fifty day moving average of $231.92 and a 200-day moving average of $222.95. The firm has a market capitalization of $36.90 billion, a PE ratio of 56.00, a price-to-earnings-growth ratio of 1.89 and a beta of 0.88.
Analysts Set New Price Targets
VEEV has been the topic of a number of recent research reports. Royal Bank of Canada upped their price target on shares of Veeva Systems from $275.00 to $285.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Truist Financial increased their price target on shares of Veeva Systems from $210.00 to $217.00 and gave the company a "hold" rating in a report on Thursday, March 6th. Evercore ISI lifted their price target on Veeva Systems from $220.00 to $245.00 and gave the stock an "in-line" rating in a research report on Friday, December 6th. Citigroup lifted their target price on Veeva Systems from $281.00 to $307.00 and gave the stock a "buy" rating in a report on Monday, December 9th. Finally, Stifel Nicolaus increased their price target on Veeva Systems from $240.00 to $272.00 and gave the company a "buy" rating in a report on Friday, December 6th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $256.52.
Read Our Latest Stock Analysis on Veeva Systems
About Veeva Systems
(
Free Report)
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
Before you consider Veeva Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.
While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
